[MNPR] YoY Quarter Result on 31-Mar-2019 [#Q1]

Stock
[MNPR] Monopar Therapeutics Inc.
Announcement Date
10-May-2019
Financial Year
2019
Quarter
31-Mar-2019 [#Q1]
Profit Trend
QoQ- -54.61%
YoY- -57.08%
Quarter Report
MNPR's Result
MNPR's Financial Summary
View:
Show?
Quarter Result
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -2,457 -1,884 -1,091 -1,376 -876 -373 -336 39.29%
Tax -1 -1,895 -1,136 -1,407 -897 -374 1 -
NP -2,456 -1,884 -1,091 -1,376 -876 -373 -336 39.28%
Tax Rate - - - - - - - -
Total Cost 2,456 1,884 1,091 1,376 876 373 336 39.28%
Ratio Analysis
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
EPS -0.19 -0.16 -0.10 -0.13 -0.08 -0.04 -0.04 29.63%
EPS Diluted -0.19 -0.16 -0.10 -0.13 -0.08 -0.04 -0.04 29.63%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.